Rajwinder Aujla
Cipla EU Ltd., UNITED KINGDOM
Medical Science Liaison Officer
Dr. Maja Beilmann-Schramm
msl-excellence, GERMANY
Founder and CEO
She has been working in the pharmaceutical industry for over 24 years. Among other roles, she has held several leadership positions in Medical Affairs at national, regional, and global levels. Until 2024, she served for many years as Director Global Field Medical Excellence & HCP Exchange at Merck before starting her career as a consultant, trainer, and coach.
More information please click here.
Alexander Maur
Kanzlei am Ärztehaus Partnerschaft mbB, Cologne (Bayenthal), GERMANY
Lawyer and Partner;
Alexander Maur has been a partner at the law firm am Ärztehaus since 2007 and advises the healthcare industry on issues relating to pharmaceutical and medical device law and associated areas of law at the firm's Cologne-Bayenthal office.
More information please click here.
Dr. Gaetano Pellitteri
Syneos Health Commercial Solutions, ITALY
Senior Director Medical Affairs Operations Gaetano joined Syneos Health in 2021, and brings nearly 20 years of biopharma experience, specialising in Medical Affairs, rare diseases, and launch support. He has extensive experience guiding MSL teams and cross-functional collaboration and holds a degree in Pharmaceutical Chemistry and Technology from the University of Palermo, along with advanced degrees in clinical research, public relations, and business.
Dr. Felix Scherg
AstraZeneca GmbH, GERMANY
Medical Evidence Lead
10/03/2026
10/03/2026
09:00 am - 05:00 pm
online
online
Event - 1,290€ plus tax
The fee includes high-quality course materials (available for download), a certificate of participation, access to our Learning Space and technical support, including a test meeting.
Event - 1,290€ plus tax
The fee includes high-quality course materials (available for download), a certificate of participation, access to our Learning Space and technical support, including a test meeting.
Leila Dörfler
Team Leader Pharma & Healthcare
+49 6221 500-695
l.doerfler@forum-institut.de
The European healthcare landscape is evolving - and so is the role of Medical Science Liaisons (MSLs). This one-day seminar provides an update on key regulatory changes, the growing impact of digital health and AI, and the increasing relevance of real-world evidence (RWE).
The European healthcare environment is evolving rapidly - and with it, the role of Medical Science Liaisons (MSLs). This seminar provides an update on current and upcoming changes that directly affect MSL activities across Europe. Participants will gain a deeper understanding of regulatory developments, digital innovation, and the increasing importance of real-world evidence (RWE) in scientific communication.
09:00 Welcome and Introduction
09:15
Dr. Gaetano Pellitteri
09:45
Alexander Maur
10:45 Coffee Break
11:00
Dr. Felix Scherg
12:15 Lunch Break
13:15
Dr. Maja Beilmann-Schramm
14:30
Dr. Gaetano Pellitteri
15:45 Coffee Break
16:00
Rajwinder Aujla
17:00 End of the seminar
of 5 stars of all ratings from 2024
of 5 stars on Trustpilot = good
We will focus on how to integrate compliance and governance into Medical Affairs activities and ensure quality documenta...
The seminar covers essential topics such as stakeholder identification, effective meeting preparation, and legally compl...